← Back to Clinical Trials
Recruiting NCT06309160

NCT06309160 COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06309160
Status Recruiting
Phase
Sponsor Ball State University
Condition Autism
Study Type INTERVENTIONAL
Enrollment 297 participants
Start Date 2023-12-01
Primary Completion 2027-07

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
COMPASS Across Settings (CAST)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 297 participants in total. It began in 2023-12-01 with a primary completion date of 2027-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Purpose: The purpose of this project is to develop and test the COMPASS \[Collaborative Model for Competence and Success\] Across Settings (CAST) intervention to enhance the goal setting and attainment skills of autistic youth. Despite federal education law mandating transition services as part of the Individualized Education Program (IEP) for ensuring good outcomes for students with disabilities, current educational practices have been unable to demonstrate that autistic students experience positive postsecondary outcomes. There are existing, evidence-based interventions aimed at supporting positive outcomes for these students. However, these interventions have not systematically provided coaching support to the caregivers, students, and employment specialists. To address these issues, CAST will integrate three evidence-based interventions for supporting student transitions while providing this critical coaching support. By doing so, CAST aims to align the priorities and goals of interventions across home, school, and community settings to better support positive postsecondary outcomes for autistic students.

Eligibility Criteria

Inclusion Criteria: * Students with verified autism and IEPs that designate services for autism * Caregivers of students with autism * Special education teachers of students with autism * Pre-employment specialists of students with autism Exclusion Criteria: * Not planning to move or leave their job over the school year

Contact & Investigator

Central Contact

Lisa A Ruble, PhD

✉ lisa.ruble@gmail.com

📞 765-285-5702

Frequently Asked Questions

Who can join the NCT06309160 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, up to 99 Years, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06309160 currently recruiting?

Yes, NCT06309160 is actively recruiting participants. Contact the research team at lisa.ruble@gmail.com for enrollment information.

Where is the NCT06309160 trial being conducted?

This trial is being conducted at Muncie, United States.

Who is sponsoring the NCT06309160 clinical trial?

NCT06309160 is sponsored by Ball State University. The trial plans to enroll 297 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology